Stay updated on SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma
Sign up to get notified when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.

Latest updates to the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page
- ChecktodayChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page metadata.SummaryDifference0.0%

- Check8 days agoChange Detected- Revision: v3.4.3 was added. - Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedAdded Revision: v3.4.2; the previous notices including Revision: v3.4.1 about government funding lapse and NIH Clinical Center operating status were removed.SummaryDifference0.4%

- Check43 days agoChange DetectedThe page now displays a government funding lapse notice with open-status guidance and a new release version labeled v3.4.1, replacing the previous v3.4.0. These updates are site-wide notices rather than alterations to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedUI updates include a Show glossary option and minor textual/casing changes to QC-related labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and a new Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check65 days agoChange DetectedRevision labels updated from v3.3.3 to v3.3.4; this is a minor backend/version update and does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma
Enter your email address, and we'll notify you when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.